PYURF | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
natural killer cell	29 studies	29% ± 9%	Explore
fibroblast	28 studies	32% ± 13%	Explore
endothelial cell	26 studies	36% ± 15%	Explore
CD4-positive, alpha-beta T cell	26 studies	27% ± 6%	Explore
CD8-positive, alpha-beta T cell	26 studies	28% ± 8%	Explore
smooth muscle cell	23 studies	31% ± 10%	Explore
conventional dendritic cell	23 studies	28% ± 14%	Explore
B cell	21 studies	24% ± 8%	Explore
pericyte	21 studies	33% ± 11%	Explore
T cell	20 studies	27% ± 10%	Explore
regulatory T cell	20 studies	29% ± 8%	Explore
macrophage	18 studies	23% ± 7%	Explore
basal cell	16 studies	31% ± 16%	Explore
plasmacytoid dendritic cell	16 studies	28% ± 11%	Explore
naive B cell	16 studies	21% ± 4%	Explore
memory B cell	16 studies	24% ± 6%	Explore
mature NK T cell	15 studies	28% ± 8%	Explore
endothelial cell of lymphatic vessel	14 studies	30% ± 9%	Explore
CD16-positive, CD56-dim natural killer cell, human	14 studies	30% ± 8%	Explore
ciliated cell	14 studies	30% ± 15%	Explore
classical monocyte	14 studies	25% ± 10%	Explore
connective tissue cell	14 studies	34% ± 11%	Explore
gamma-delta T cell	14 studies	33% ± 11%	Explore
mast cell	13 studies	24% ± 4%	Explore
non-classical monocyte	13 studies	28% ± 13%	Explore
epithelial cell	13 studies	36% ± 21%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	12 studies	28% ± 7%	Explore
CD16-negative, CD56-bright natural killer cell, human	12 studies	30% ± 9%	Explore
myofibroblast cell	12 studies	35% ± 15%	Explore
CD8-positive, alpha-beta memory T cell	11 studies	30% ± 8%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	11 studies	33% ± 5%	Explore
capillary endothelial cell	11 studies	28% ± 10%	Explore
monocyte	11 studies	24% ± 7%	Explore
mucosal invariant T cell	11 studies	30% ± 9%	Explore
vein endothelial cell	10 studies	30% ± 8%	Explore
endothelial cell of vascular tree	10 studies	33% ± 7%	Explore
CD4-positive, alpha-beta memory T cell	9 studies	30% ± 7%	Explore
secretory cell	9 studies	26% ± 11%	Explore
effector memory CD8-positive, alpha-beta T cell	9 studies	30% ± 12%	Explore
endothelial cell of artery	9 studies	31% ± 7%	Explore
plasma cell	8 studies	26% ± 9%	Explore
dendritic cell	8 studies	44% ± 25%	Explore
progenitor cell	7 studies	30% ± 8%	Explore
T follicular helper cell	7 studies	26% ± 5%	Explore
club cell	6 studies	23% ± 9%	Explore
effector CD8-positive, alpha-beta T cell	6 studies	30% ± 5%	Explore
epithelial cell of proximal tubule	6 studies	25% ± 7%	Explore
innate lymphoid cell	6 studies	27% ± 6%	Explore
myeloid cell	6 studies	27% ± 11%	Explore
hematopoietic precursor cell	5 studies	48% ± 19%	Explore
plasmablast	5 studies	39% ± 19%	Explore
exhausted T cell	5 studies	34% ± 3%	Explore
kidney loop of Henle epithelial cell	5 studies	27% ± 3%	Explore
mesothelial cell	5 studies	43% ± 20%	Explore
erythroblast	5 studies	46% ± 21%	Explore
hematopoietic stem cell	5 studies	41% ± 13%	Explore
precursor B cell	5 studies	27% ± 11%	Explore
pro-B cell	5 studies	33% ± 4%	Explore
effector memory CD4-positive, alpha-beta T cell	5 studies	31% ± 11%	Explore
leukocyte	4 studies	27% ± 5%	Explore
mononuclear phagocyte	4 studies	33% ± 18%	Explore
kidney distal convoluted tubule epithelial cell	4 studies	37% ± 6%	Explore
enteroendocrine cell	4 studies	36% ± 17%	Explore
goblet cell	4 studies	29% ± 15%	Explore
intestinal crypt stem cell	4 studies	24% ± 7%	Explore
transit amplifying cell	4 studies	18% ± 1%	Explore
abnormal cell	4 studies	27% ± 4%	Explore
immature B cell	4 studies	30% ± 17%	Explore
type II pneumocyte	4 studies	33% ± 14%	Explore
effector CD4-positive, alpha-beta T cell	4 studies	35% ± 3%	Explore
luminal hormone-sensing cell of mammary gland	4 studies	37% ± 9%	Explore
neuron	4 studies	34% ± 19%	Explore
erythrocyte	4 studies	36% ± 18%	Explore
T-helper 17 cell	4 studies	29% ± 5%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	4 studies	33% ± 7%	Explore
duct epithelial cell	3 studies	18% ± 2%	Explore
glomerular endothelial cell	3 studies	26% ± 6%	Explore
renal alpha-intercalated cell	3 studies	35% ± 7%	Explore
enterocyte	3 studies	18% ± 3%	Explore
neural crest cell	3 studies	32% ± 6%	Explore
retinal ganglion cell	3 studies	51% ± 27%	Explore
common myeloid progenitor	3 studies	43% ± 23%	Explore
lymphocyte	3 studies	33% ± 9%	Explore
type I pneumocyte	3 studies	31% ± 12%	Explore
amacrine cell	3 studies	35% ± 14%	Explore
astrocyte	3 studies	34% ± 18%	Explore
alveolar macrophage	3 studies	31% ± 3%	Explore
intraepithelial lymphocyte	3 studies	26% ± 4%	Explore
Mueller cell	3 studies	27% ± 9%	Explore
oligodendrocyte	3 studies	21% ± 5%	Explore
glial cell	3 studies	38% ± 22%	Explore
group 3 innate lymphoid cell	3 studies	35% ± 11%	Explore
keratinocyte	3 studies	33% ± 10%	Explore
T-helper 1 cell	3 studies	30% ± 6%	Explore
megakaryocyte-erythroid progenitor cell	3 studies	62% ± 20%	Explore
double negative thymocyte	3 studies	48% ± 15%	Explore
progenitor cell of mammary luminal epithelium	3 studies	35% ± 5%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
lung	14 studies	27% ± 14%	Explore
peripheral blood	14 studies	31% ± 8%	Explore
intestine	9 studies	27% ± 14%	Explore
kidney	7 studies	27% ± 3%	Explore
liver	6 studies	27% ± 21%	Explore
bone marrow	4 studies	24% ± 7%	Explore
uterus	4 studies	34% ± 11%	Explore
lymph node	4 studies	23% ± 3%	Explore
breast	4 studies	29% ± 5%	Explore
eye	3 studies	33% ± 12%	Explore
adrenal gland	3 studies	19% ± 4%	Explore
prostate	3 studies	23% ± 7%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Number of samples
adipose	96%	5.32	1152 / 1204	0%	0 / 0
adrenal gland	95%	5.34	246 / 258	0%	0 / 230
uterus	95%	5.08	161 / 170	0%	0 / 459
blood vessel	94%	4.99	1256 / 1335	0%	0 / 0
skin	94%	5.28	1700 / 1809	0%	0 / 472
ovary	94%	4.57	169 / 180	0%	0 / 430
breast	93%	5.17	426 / 459	0%	0 / 1118
esophagus	93%	4.40	1339 / 1445	0%	0 / 183
thymus	93%	3.97	605 / 653	0%	0 / 605
intestine	91%	4.31	876 / 966	0%	0 / 527
lung	90%	4.11	523 / 578	0%	0 / 1155
muscle	90%	3.83	723 / 803	0%	0 / 0
brain	89%	3.46	2355 / 2642	0%	0 / 705
kidney	89%	3.34	79 / 89	0%	0 / 901
prostate	88%	3.27	215 / 245	0%	0 / 502
pancreas	87%	2.91	285 / 328	0%	0 / 178
bladder	86%	3.57	18 / 21	0%	0 / 504
stomach	85%	3.31	305 / 359	0%	0 / 286
spleen	84%	3.02	203 / 241	0%	0 / 0
heart	82%	2.90	709 / 861	0%	0 / 0
liver	78%	2.17	177 / 226	0%	0 / 406
peripheral blood	66%	2.10	615 / 929	0%	0 / 0
abdomen	0%	0	0 / 0	0%	0 / 0
bone marrow	0%	0	0 / 0	0%	0 / 0
diaphragm	0%	0	0 / 0	0%	0 / 0
eye	0%	0	0 / 0	0%	0 / 80
gingiva	0%	0	0 / 0	0%	0 / 0
lymph node	0%	0	0 / 0	0%	0 / 29
nasal cavity	0%	0	0 / 0	0%	0 / 0
nasopharynx	0%	0	0 / 0	0%	0 / 0
nose	0%	0	0 / 0	0%	0 / 0
placenta	0%	0	0 / 0	0%	0 / 0
spinal column	0%	0	0 / 0	0%	0 / 0
tonsil	0%	0	0 / 0	0%	0 / 45
ureter	0%	0	0 / 0	0%	0 / 1

GO_0050821	Biological process	protein stabilization
GO_0005789	Cellular component	endoplasmic reticulum membrane
GO_0005739	Cellular component	mitochondrion
GO_0005515	Molecular function	protein binding

Gene name	PYURF
Protein name	Protein preY, mitochondrial (PIGY upstream reading frame protein)
Synonyms	PREY NDUFAFQ
Description	FUNCTION: In mitochondria, S-adenosylmethionine-dependent methyltransferase chaperone that supports both coenzyme Q biosynthesis, by stabilizing its components, such as COQ5, and NADH:ubiquinone oxidoreductase complex (complex I, MT-ND1) assembly, by stabilizing complex I assembly factors, such as NDUFAF5. .
Accessions	ENST00000273968.5 Q96I23

PYURF report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review